{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:05:42Z","timestamp":1762866342585,"version":"build-2065373602"},"reference-count":24,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"vor","delay-in-days":640,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Australian and New Zealand Journal of Public Health"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1111\/1753-6405.12173","type":"journal-article","created":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T06:34:38Z","timestamp":1396334078000},"page":"160-164","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Hepatitis C testing and status among opioid substitution treatment clients in New South Wales"],"prefix":"10.1016","volume":"38","author":[{"given":"Fiona L.","family":"Shand","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolyn","family":"Day","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Rawlinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louisa","family":"Degenhardt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas G.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elliot C.","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2011","series-title":"HIV Aids, Viral Hepatitis and Sexually Transmissable Infections in Australia: Annual Surveillance Report","key":"10.1111\/1753-6405.12173_azph12173-bib-0001"},{"issue":"9791","key":"10.1111\/1753-6405.12173_azph12173-bib-0002","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0140-6736(11)61097-0","article-title":"Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews","volume":"378","author":"Nelson","year":"2011","journal-title":"Lancet"},{"key":"10.1111\/1753-6405.12173_azph12173-bib-0003","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1111\/j.1360-0443.2011.03575.x","article-title":"The increasing mortality burden of liver disease among opioid dependent people: Cohort study","volume":"106","author":"Gibson","year":"2011","journal-title":"Addiction"},{"issue":"1","key":"10.1111\/1753-6405.12173_azph12173-bib-0004","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.2196\/jmir.1857","article-title":"MEMO\u2010A mobile phone depression prevention intervention for adolescents: Development process and postprogram findings on acceptability from a randomized controlled trial","volume":"14","author":"Whittaker","year":"2012","journal-title":"J Med Internet Res"},{"issue":"9859","key":"10.1111\/1753-6405.12173_azph12173-bib-0005","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1016\/S0140-6736(12)61689-4","article-title":"Disability\u2010adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990\u20132010: A systematic analysis for the Global Burden of Disease Study","volume":"380","author":"Murray","year":"2010","journal-title":"Lancet"},{"issue":"9904","key":"10.1111\/1753-6405.12173_azph12173-bib-0006","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/S0140-6736(13)61530-5","article-title":"The global burden of disease attributable to illicit drug use and dependence: findings from the Global Burden of Disease Study 2010","volume":"382","author":"Degenhardt","year":"2013","journal-title":"Lancet"},{"issue":"7","key":"10.1111\/1753-6405.12173_azph12173-bib-0007","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1093\/cid\/cit377","article-title":"Elimination of hepatitis C virus infection among people who inject drugs through treatment as prevention: Feasibility and future requirements","volume":"57","author":"Grebely","year":"2013","journal-title":"Clin Infect Dis."},{"year":"2011","series-title":"The Hepatitis C Treatment Pipeline Report.","author":"Swan","key":"10.1111\/1753-6405.12173_azph12173-bib-0008"},{"issue":"11","key":"10.1111\/1753-6405.12173_azph12173-bib-0009","doi-asserted-by":"crossref","first-page":"560","DOI":"10.5694\/j.1326-5377.2006.tb00380.x","article-title":"National survey of HIV and hepatitis testing and vaccination services provided by drug and alcohol agencies in Australia","volume":"184","author":"Winstock","year":"2006","journal-title":"Med J Aust"},{"issue":"Suppl 2","key":"10.1111\/1753-6405.12173_azph12173-bib-0010","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.1093\/cid\/cit305","article-title":"Assessment and treatment of hepatitis C virus infection among people who inejct drugs in the opioid subsitution setting: The ETHOS Study","volume":"57","author":"Alavi","year":"2013","journal-title":"Clin Infect Dis"},{"year":"2013","series-title":"Australian Needle and Syringe Program Survey National Data Report 2008\u20132013","author":"Iversen","key":"10.1111\/1753-6405.12173_azph12173-bib-0011"},{"issue":"8","key":"10.1111\/1753-6405.12173_azph12173-bib-0012","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.2105\/AJPH.2012.301206","article-title":"Reduction in HCV incidence among injection drug users attending needle and syringe programs in Australia: a linkage study","volume":"103","author":"Iversen","year":"2013","journal-title":"Am J Public Health"},{"issue":"1\u20132","key":"10.1111\/1753-6405.12173_azph12173-bib-0013","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.addbeh.2010.08.008","article-title":"Sex differences among dependent heroin users: histories, clinical characteristics and predictors of other substance dependence","volume":"36","author":"Shand","year":"2011","journal-title":"Addict Behav."},{"year":"1994","series-title":"Diagnostic and Statistical Manual of Mental Disorders","key":"10.1111\/1753-6405.12173_azph12173-bib-0014"},{"year":"1987","series-title":"Diagnostic and Statistical Manual of Mental Disorders","key":"10.1111\/1753-6405.12173_azph12173-bib-0015"},{"key":"10.1111\/1753-6405.12173_azph12173-bib-0016","doi-asserted-by":"crossref","first-page":"149","DOI":"10.15288\/jsa.1994.55.149","article-title":"A new, semi\u2010structured psychiatric interview for use in genetic linkage studies: A report on the reliability of SSAGA","volume":"55","author":"Bucholz","year":"1994","journal-title":"J Stud Alcohol"},{"issue":"9","key":"10.1111\/1753-6405.12173_azph12173-bib-0017","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1046\/j.1360-0443.1999.94913618.x","article-title":"A validity study of the SSAGA \u2013 a comparison with the SCAN","volume":"94","author":"Hesselbrock","year":"1999","journal-title":"Addiction"},{"issue":"11","key":"10.1111\/1753-6405.12173_azph12173-bib-0018","doi-asserted-by":"crossref","first-page":"4346","DOI":"10.1128\/JCM.40.11.4346-4348.2002","article-title":"Quantification of hepatitis C virus in human liver and serum samples by using LightCycler reverse transcriptase PCR","volume":"40","author":"White","year":"2002","journal-title":"J Clin Microbiol"},{"key":"10.1111\/1753-6405.12173_azph12173-bib-0019","series-title":"Hepatitis C: An Expanding Focus","first-page":"288","article-title":"Managing drug dependence in people with hepatitis C","author":"Day","year":"2009"},{"key":"10.1111\/1753-6405.12173_azph12173-bib-0020","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.drugalcdep.2007.05.026","article-title":"Modelling the hepatitis C virus epidemic in Australia","volume":"91","author":"Razali","year":"2007","journal-title":"Drug Alcohol Depend"},{"issue":"5","key":"10.1111\/1753-6405.12173_azph12173-bib-0021","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1023\/A:1007622831518","article-title":"HCV status knowledge and risk behaviours among intravenous drug users","volume":"16","author":"Vidal\u2010Tr\u00e9can","year":"2000","journal-title":"Eur J Epidemiol"},{"issue":"10","key":"10.1111\/1753-6405.12173_azph12173-bib-0022","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1046\/j.1360-0443.2002.00208.x","article-title":"The association between knowledge of hepatitis C virus status and risk behaviors in injection drug users","volume":"97","author":"Kwiatkowski","year":"2002","journal-title":"Addiction"},{"issue":"6","key":"10.1111\/1753-6405.12173_azph12173-bib-0023","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1177\/003335490612100611","article-title":"Self\u2010reported hepatitis C virus antibody status and risk behavior in young injectors","volume":"121","author":"Hagan","year":"2006","journal-title":"Public Health Rep"},{"issue":"12","key":"10.1111\/1753-6405.12173_azph12173-bib-0024","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1016\/j.addbeh.2008.07.005","article-title":"Injecting drug users\u2019 understanding of hepatitis C","volume":"33","author":"O'Brien","year":"2008","journal-title":"Addict Behav"}],"container-title":["Australian and New Zealand Journal of Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2F1753-6405.12173","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2F1753-6405.12173","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1326020023023142?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1326020023023142?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/1753-6405.12173\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T18:29:28Z","timestamp":1761157768000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1326020023023142"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["S1326020023023142"],"URL":"https:\/\/doi.org\/10.1111\/1753-6405.12173","relation":{},"ISSN":["1326-0200"],"issn-type":[{"type":"print","value":"1326-0200"}],"subject":[],"published":{"date-parts":[[2014,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatitis C testing and status among opioid substitution treatment clients in New South Wales","name":"articletitle","label":"Article Title"},{"value":"Australian and New Zealand Journal of Public Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/1753-6405.12173","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright 2014 THE AUTHORS.","name":"copyright","label":"Copyright"}]}}